ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2629

Predictors of 30-day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Impact of Social Determinants of Health.

Sandhya Kannayiram1, Yiyuan Wu2, Lisa Sammaritano3, Michael Lockshin4, Rich Caruana5, Ware Branch6, Jane Salmon3 and Bella Mehta7, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5Microsoft, Redmond, WA, 6University of Utah Health Sciences Center, Salt Lake City, UT, 7Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ

Meeting: ACR Convergence 2025

Keywords: Disparities, pregnancy, socioeconomic factors, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: Abstracts: Reproductive Issues in Rheumatic Disorders (2627–2632)

Session Type: Abstract Session

Session Time: 3:30PM-3:45PM

Background/Purpose: Social Determinants of Health (SDOH) are increasingly recognized as significant contributors to adverse outcomes in pregnant patients with SLE. This study aims to evaluate the impact of SDOH on 30-day readmissions during pregnancy- and delivery-related hospitalizations in SLE patients, hypothesizing that incorporating SDOH into predictive models will enhance understanding of readmission risks and outcomes.

Methods: We conducted a retrospective analysis using the National Readmissions Database (NRD) from 2011 to 2021, which covers 28 states and represents 60% of U.S. hospitalizations. We identified adult pregnant patients with SLE using ICD-9 and 10 codes and categorized them into pregnancy- and delivery-related hospitalizations, including delivery cases within the pregnancy cohort. Our primary outcome was 30-day all-cause readmissions, and secondary outcomes included length of stay(LOS) and total hospitalization charges(THC). The SDOH evaluated in the study consists of income by zip code and insurance type. Descriptive analyses compared age, SDOH, clinical factors, LOS, and THC between initial hospitalizations and 30-day readmissions. We employed an Explainable Boosting Machine (EBM) model, using a 70-30 train-test split to predict readmissions based on features including comorbidities and SDOH. Weighted Mean absolute scores were aggregated globally to measure variable importance.

Results: Among pregnancy- and delivery-related hospitalizations, 3.6% resulted in readmissions, while 2.2% of delivery-related hospitalizations led to readmissions. Patients in the lowest income quartile (0–25th percentile) faced nearly double the readmission rates compared to the highest quartile (36% vs. 16% for pregnancy and delivery; 35% vs. 15% for delivery-related hospitalizations). Similarly, patients with public insurance (Medicare/Medicaid) were more likely to be readmitted, while those with private insurance/self-pay were less likely, underscoring systemic inequities (Table).SLE patients with thrombocytopenia (8.6% vs. 6.2%), hypertension (11% vs. 3.8%), pre-eclampsia/eclampsia (19% vs. 15%), or Acute kidney injury (6.4% vs. 1.7%) during pregnancy and those with pre-eclampsia/eclampsia (24% vs. 15%), renal failure (19% vs. 9.5%), pulmonary edema (3.9% vs. 1.1%), sepsis (3.6% vs. 1.1%), or thromboembolism (4.9% vs. 2.9%) during delivery had higher 30-day readmission rates[p value < 0.05].Importance analysis (AUROC ≃0.68) identified LOS, insurance type, comorbidities, hospital characteristics, income, and age as key predictors for pregnancy and delivery-related readmissions, with LOS and insurance showing the highest predictive value. Comorbidities, LOS, insurance, hospital characteristics, income, and age were top predictors for delivery-related admissions.

Conclusion: SDOH are an important predictor of readmissions in SLE patients during pregnancy and delivery. Targeted strategies focusing on improving access to resources and healthcare and addressing income disparities within disadvantaged communities may help reduce readmission rates and improve outcomes for this high-risk group.Acknowledgements: K23 Grant Award Number – 1K23AR082991-01A1

Supporting image 1Table : A Comparative Analysis of Demographics and Social Determinants of Health for Pregnant Patients with Systemic Lupus Erythematosus during Initial Hospitalizations and 30-Day Readmissions.

Supporting image 2Figure: Feature Importance Scores for predicting 30-Day Readmissions in SLE patients during pregnancy and delivery-related hospitalizations.


Disclosures: S. Kannayiram: None; Y. Wu: None; L. Sammaritano: None; M. Lockshin: None; R. Caruana: None; W. Branch: UCB, 5; J. Salmon: UCB, 1, 5; B. Mehta: Amgen, 1, Horizon, 1.

To cite this abstract in AMA style:

Kannayiram S, Wu Y, Sammaritano L, Lockshin M, Caruana R, Branch W, Salmon J, Mehta B. Predictors of 30-day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Impact of Social Determinants of Health. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/predictors-of-30-day-readmissions-in-pregnant-patients-with-systemic-lupus-erythematosus-the-impact-of-social-determinants-of-health/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-30-day-readmissions-in-pregnant-patients-with-systemic-lupus-erythematosus-the-impact-of-social-determinants-of-health/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology